A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis
Clinical trial NCT06159725 · COMPLETED
Trial details
- NCT number
- NCT06159725
- Sponsor
- Clarametyx Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-24
- Primary completion
- 2025-11-14
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.